Yukon government releases webpage with resources on long COVID (News)

Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc [More Details]

Medical Professionals Become an LDN Specialist [More Details]

Submitted by baileylynn_100964 on Tue, 12/13/2022 - 09:32

Yukon government releases webpage with resources on long COVID

Yukon News
08 December 2022

The Yukon government acknowledged long COVID exists in a wide range of diverse and long-term effects in some people who have been infected with COVID-19 when it announced the creation of a long COVID working group. The Yukon government released a webpage that contains resources for Yukoners with symptoms of long COVID; for their friends and families; and for health-care providers.

A clinical trial for low dose naltrexone, which ends in December, is being run out of the Complex Chronic Diseases Program at B.C. Women’s Hospital and the post-COVID-19 recovery clinics in British Columbia. In the study description, Naltrexone could help to reduce pain and inflammation and improve well-being and immune function. The study is intended to demonstrate whether low doses of the drug could benefit a large number of people with post-COVID fatigue syndrome.